Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 2/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.34 |
| ▸ | CASR | P41180 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.33 |
| ▸ | PRKG1 | Q13976 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3674930 | 0.88 | KCNA5 (0.45) | ADRA2AADRA1ATAAR1AOC3TDP1 | |
| SCHEMBL3668500 | 0.87 | CFB (0.35) | ADRA2AADRA1ATAAR1AOC3 | |
| SCHEMBL3670065 | 0.80 | TAAR1 (0.38) | ADRA2AADRA1ATAAR1 | |
| SCHEMBL3669311 | 0.79 | CFB (0.36) | ADRA2AADRA1ATAAR1 | |
| SCHEMBL1157345 | 0.79 | ADRA2A (0.46) | ADRA2AADRA1ATAAR1AOC3MTNR1A | |
| SCHEMBL3665641 | 0.79 | ADRA2A (0.33) | ADRA2AADRA1ATAAR1 | |
| SCHEMBL3415420 | 0.73 | ADRA2A (0.41) | ADRA2AADRA1ATAAR1AOC3THRB | |
| SCHEMBL3666286 | 0.72 | SLC6A3 (0.43) | ADRA2AKCNA5 | |
| SCHEMBL3671172 | 0.71 | CFB (0.36) | ADRA2AADRA1ATAAR1AOC3 | |
| SCHEMBL3804488 | 0.71 | TAAR1 (0.40) | ADRA2AADRA1ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2242753-A1 | OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-10-27 | — | — | EP | disclosed |
| EP-2240468-A1 | SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009091760-A1 | OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2009-07-23 | — | — | WO | disclosed |
| WO-2009091759-A1 | SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2009-07-23 | — | — | WO | disclosed |